(URIROX-2) Establishing the Safety and Efficacy of Reloxaliase (Oxalate Decarboxylase) in Patients with Enteric Hyperoxaluria The PI of this project is: This project is funded by: Allena Pharmaceuticals, Inc. The term of this project is: April 2019 to May 2025 The number of subjects scanned during this project is: 5